Is This $375 Million Cannabis Stock Too Good to Be True?

stock data

Following the industry bear market of 2019, many thought cannabis stocks would recover. Then came the coronavirus pandemic. Today, valuations remain 80% below their peak.

Marijuana companies are still hurting. Just look at Hexo (TSX:HEXO)(NYSE:HEXO). This $375 million business was once valued at $2 billion!

But this is far from the end. Marijuana consumption continues to rise, and companies are figuring out how to turn a hefty profit. For daring investors, this is the chance to make 10 times your original investment.

How to profit

While fortunes will be made during the next boom, not all cannabis stocks are created equal. Some will have significantly more upside.

Your best bet is to find companies that can overcome the effects of commoditization. This should be your number one priority.

Last year, before the marijuana bear market, I warned investors about the number one risk the industry faces.

“In the end, most cannabis production is not differentiated,” I explained. “That means it will sell at the same price per volume as any other cannabis.”

I stressed that the effects of commoditization will drive cannabis stocks for years to come.

“Importantly, commoditization also means that if prices get too attractive, new supply will be added to the market, pushing prices down over the long term,” I added. “Most importantly, it also means that suppliers will push hard to reduce costs; the only way to reliably make money in a commoditized market is to have a low-cost position.”

In order to profit with cannabis stocks, you need to find companies that can overcome this challenge. The best long-term strategy is through differentiation.

For example, Coca-Cola sells commoditized ingredients, but the company packages them in a way that achieves high pricing power. Consumers are willing to pay a big premium for water and sugar, as long as it says Coke on the bottle.

Marijuana companies must chart the same course. They need to figure out how to make customers loyal to value-add products that can withstand pricing erosion.

This cannabis stock will win

Despite a valuation of just $375 million, Hexo has a big lead in creating differentiated marijuana products. This was all part of its plan.

When cannabis stocks first took off in 2018, every producer rushed to bring supply online. Hexo was unique in that it focused on differentiation. That’s why it created the industry’s first cannabis platform. It provides the basic infrastructure that other brands can tap into.

For example, Hexo has a partnership with Molson Coors (TSX:TPX.B)(NYSE:TAP) to co-produce THC-infused beverages. Hexo provides the marijuana expertise, while Molson lends its globally-recognized brand.

Long term, cannabis stocks like Hexo will win. Marijuana consumption continues to grow, and certain brands will rise to the top. By partnering with existing brands that consumers already know and love, Hexo can leap ahead of the competition.

In some ways, Hexo mirrors the successful business model of tech stocks like Shopify, which simply build the basic infrastructure, allowing others to build on top. Shopify stock rose 30 times in value in just five years. Hexo could emulate that rise.

We like the stock below even more than Hexo and Shopify.

This Tiny TSX Stock Could Be the Next Shopify

One little-known Canadian IPO has doubled in value in a matter of months, and renowned Canadian stock picker Iain Butler sees a potential millionaire-maker in waiting…
Because he thinks this fast-growing company looks a lot like Shopify, a stock Iain officially recommended 3 years ago – before it skyrocketed by 1,211%!
Iain and his team just published a detailed report on this tiny TSX stock. Find out how you can access the NEXT Shopify today!

Click here to discover how!

More reading

Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Shopify and Shopify. The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned.

The post Is This $375 Million Cannabis Stock Too Good to Be True? appeared first on The Motley Fool Canada.

Source: The Fool
Is This 5 Million Cannabis Stock Too Good to Be True?
The Fool

The Motley Fool
Contributor at mjcanada.ca
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related News